Atra stock forecast.

SmartAssetPaid Partner. Find real-time T - AT&T Inc stock quotes, company profile, news and forecasts from CNN Business.Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...Oct 26, 2023 · Atara Biotherapeutics Stock Forecast 10 Nov. Presumably, on 11/10/2023, the price of shares will be in the range of $1.31 - $1.36. A $0.05 range width can provide 3.98% volatility. The weighted average price of this range is at $1.34, which is $0.00 lower than the previous day's weighted average price. NTRA Stock 12 Months Forecast. $70.40. (31.54% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $70.40 with a high forecast of $87.00 and a low forecast of $48.00. The average price target represents a 31.54% change from the last price of $53.52.Oct 9, 2023 · Atara Biotherapeutics stock forecast for Apr 2025. Estimated Average Forecasted Atara Biotherapeutics Price: 1.93. Positive monthly dynamics of the instrument is expected with 6.030% volatility is expected. Pessimistic forecast: 1.88. Optimistic: 2.00. Atara Biotherapeutics stock forecast for May 2025.

S Stock 12 Months Forecast. Based on 20 Wall Street analysts offering 12 month price targets for SentinelOne in the last 3 months. The average price target is $18.97 with a high forecast of $23.00 and a low forecast of $16.50. The average price target represents a 5.86% change from the last price of $17.92.Nov 16, 2023 · It follows that stock’s current price would drop -7268.42% in reaching the projected high whereas dropping to the targeted low would mean a loss of -31.58% for stock’s current value. Atara Biotherapeutics Inc (ATRA) estimates and forecasts

Real time Atara Biotherapeutics (ATRA) stock price quote, stock graph, news & analysis.

Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.The latest Atara Biotherapeutics stock prices, stock quotes, news, and ATRA history to help you invest and trade smarter. ... The 18 analysts offering price forecasts for Atara Biotherapeutics ...During the last day, the stock moved $0.1000 between high and low, or 1.40%. For the last week, the stock has had daily average volatility of 1.24% . Our recommended stop-loss: $6.83 (-5.75%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 19 days ago.)Based on short-term price targets offered by 16 analysts, the average price target for Alibaba comes to $126.50. The forecasts range from a low of $100.00 to a high of $150.00. The average price ...

18 brokerages have issued 1-year price objectives for ChargePoint's shares. Their CHPT share price targets range from $2.00 to $17.00. On average, they expect the company's share price to reach $9.13 in the next year. This suggests a possible upside of 380.1% from the stock's current price.

Stock Price Forecast. According to 38 stock analysts, the average 12-month stock price forecast for Microsoft stock is $392, which predicts an increase of 3.45%. The lowest target is $263 and the highest is $475. On average, analysts rate Microsoft stock as a strong buy.

ATRA forecast by analyst 3. Atara Biotherapeutics stock fundamental checker 4. ATRA social sentiment 5. Analyzing Atara Biotherapeutics (ATRA) Stock Forecast in the …This rich reservoir of information aids in informed decision-making, blending historical data with future predictions to paint a holistic picture of stock performance trajectories. …We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...Atara Biotherapeutics (ATRA) Slumps 57% in a Month: Here's Why. Atara's (ATRA) shares fell after a phase II study evaluating its multiple sclerosis therapy did not meet its primary …Nov 30, 2023 · What is the current Price Target and Forecast for Atara Biotherapeutics (ATRA) Atara Biotherapeutics (ATRA) (Delayed Data from NSDQ) $0.51 USD +0.03 (6.14%) Updated Nov 17, 2023 04:00 PM ET...

Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Are you tired of spending countless hours manually tracking your inventory? Are you looking for a way to improve your decision making and forecasting processes? Look no further than a free inventory tracking template.Dec 1, 2023 · Their ATRA share price targets range from $25.00 to $31.00. On average, they expect the company's stock price to reach $28.00 in the next year. This suggests a possible upside of 4,490.2% from the stock's current price. View analysts price targets for ATRA or view top-rated stocks among Wall Street analysts. Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for ATRA stock stock is $12.15, which predicts an increase of 1,655.27%. The lowest target is $0.50 and the highest is $25. On average, analysts rate ATRA stock stock as a hold.Based on analysts offering 12 month price targets for ATRA in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

On November 2, 2023, Atara Biotherapeutics Inc (ATRA) experienced a significant surge in its stock performance following positive price forecasts from analysts. According to data from CNN Money, seven analysts have offered 12-month price forecasts for ATRA, with a median target of $19.00.

2 Wall Street research analysts have issued twelve-month price objectives for Nano-X Imaging's shares. Their NNOX share price targets range from $14.50 to $30.00. On average, they anticipate the company's stock price to reach $22.25 in the next year. This suggests a possible upside of 253.7% from the stock's current price.CYBN Stock 12 Months Forecast. $5.50. (1067.48% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cybin in the last 3 months. The average price target is $5.50 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 1067.48% change from the last price of $0.47.NTRA Stock 12 Months Forecast. $70.40. (31.54% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $70.40 with a high forecast of $87.00 and a low forecast of $48.00. The average price target represents a 31.54% change from the last price of $53.52.About. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...$0.65. DRRX 5.13%. Outlook Therapeutics Inc. $0.47. OTLK 1.50%. Gamida Cell Ltd. $0.33. GMDA 6.45%. Atara Biotherapeutics Inc. $0.65. ATRA 1.85%. Aclaris ...Based on the future market’s prediction, the third quarter of 2023 will see the interest peak at around 3.8%. Source: ASX. However, the months ahead in the new calendar will also have the opportunity to see the inception point finally arrived for the local monetary policy. Even with the absence of the first rate-cut to occur, the pause of the ...Find real-time MULN - Mullen Automotive Inc stock quotes, company profile, news and forecasts from CNN Business.

Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -4.62% and 71.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

The Atara Biotherapeutics stock forecast for tomorrow is $ 0.237094, which would represent a -1.21% loss compared to the current price. In the next week, the price of ATRA is expected to increase by 2.28% and hit $ 0.245483. As far as the long-term Atara Biotherapeutics stock forecast is ...

This year’s forecast. As for the 2023 expectation, City analysts currently think AstraZeneca will reward investors with a payout of $3.06 per share. That would represent a third consecutive ...NTRA Stock 12 Months Forecast. $70.40. (31.54% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $70.40 with a high forecast of $87.00 and a low forecast of $48.00. The average price target represents a 31.54% change from the last price of $53.52.ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period. Orchid Island Capital (NYSE:ORC) pays an annual dividend of $1.44 per share and currently has a dividend yield of 19.54%. ORC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for ORC.16 analysts have issued twelve-month price objectives for Alibaba Group's shares. Their BABA share price targets range from $90.00 to $150.00. On average, they expect the company's share price to reach $129.20 in the next year. This suggests a possible upside of 74.6% from the stock's current price.KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62.Find real-time MULN - Mullen Automotive Inc stock quotes, company profile, news and forecasts from CNN Business.GDX Signals & Forecast. Mostly positive signals in the chart today. The VanEck Vectors Gold Miners ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long …CYBN Stock 12 Months Forecast. $5.50. (1067.48% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cybin in the last 3 months. The average price target is $5.50 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 1067.48% change from the last price of $0.47.The BOIL ETF price gained 0.81% on the last trading day (Thursday, 30th Nov 2023), rising from $36.00 to $36.29. During the last trading day the ETF fluctuated 6.05% from a day low at $35.20 to a day high of $37.33. The price has fallen in 8 of the last 10 days and is down by -29.62% for this period. Volume fell on the last day by -27 …

12/02/2023. Palantir stock price stood at $20.27. According to the latest long-term forecast, Palantir price will hit $25 by the end of 2023 and then $30 by the middle of 2025. Palantir will rise to $45 within the year of 2026, $55 in 2027, $60 in 2028, $65 in 2029, $70 in 2030, $75 in 2032, $80 in 2033, $85 in 2034 and $90 in 2035.16 equities research analysts have issued twelve-month price targets for SoFi Technologies' stock. Their SOFI share price targets range from $3.00 to $15.00. On average, they anticipate the company's share price to reach $8.78 in the next year. This suggests a possible upside of 12.1% from the stock's current price.Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.Instagram:https://instagram. roamright reviewsunlock heloc reviewsbest dental insurance in hawaiihow to set up a day trading account 16 sept 2020 ... See if the stock goes on to build a promising consolidation that could kick off a new price move. Atara Biotherapeutics (ATRA). what quarters to look forjepi ex dividend ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period. nio slips Atara Biotherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ATRA updated stock price target summary.3 Wall Street research analysts have issued 12 month price targets for Invesco Mortgage Capital's stock. Their IVR share price targets range from $10.50 to $11.00. On average, they expect the company's stock price to reach $10.75 in the next year. This suggests a possible upside of 31.0% from the stock's current price.The average Atara Biotherapeutics stock price prediction forecasts a potential upside of 1,854.55% from the current ATRA share price of $0.57. What is ATRA's forecast return on equity (ROE) for 2023-2026?